Press releaseGlobe Newswire
RetinalGenix Technologies
RTGN · OTC
$3.99+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
- Press releaseGlobe Newswire
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
- Press releaseGlobe Newswire
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.